Preparing for FDA’s 2026 Human Foods Priorities: Transparency is the New Flavor
What the Human Foods Agenda Means for Regulated Businesses
Search
Tag: Infant Formula
Infant Formula Market Resiliency
Last week, FDA announced an Immediate National Strategy to Increase the Resiliency of the U.S. Infant Formula Market. The strategy is a result of shake-up caused by the recent infant formula shortage following unsanitary conditions at one of the country’s largest infant formula facilities, which led to stand-still production for several months and a significant voluntary recall. The […]
A look at FDA’s Newly Issued Internal Report
Will FDA’s Recognition of System Vulnerabilities in its Infant Formula Response Open the Door for Alternative Supply Sources and Regulatory Changes?
★★★★★
Working with Shelly on various new product launches over the last couple of years has been seamless. Quick and clear guidance is always what we get.
I've been working with Shelly and her team at Garg law for a little while now and they are fantastic! Very responsive, professional and they certainly get things done. Extremely satisfied with their service and highly recommend.
Ms Garg helped my company navigate an FDA import issue. She achieved an excellent result, was very responsive and professional, and managed to keep the project within budget. She is a stellar attorney.
I have been using Shelly Garg as FDA Counsel for 10+ years, since she was at another international law firm. While we continued to use the previous firm she was at (mainly due to the process required to change firms), we realized the quality of counsel was not the same. We have since been using Garg Law and the ease of use and trust in the knowledge was back instantly. Shelly has the skills to help me understand the regulations (by translating into layman's terms) and risks in a manner that is specific to my business. She is also extremely timely in her responses which is critical when we have a deadline mandated by the FDA. Many other attorneys cite the regulations which l've already read, but need further counsel. In my opinion, this demonstrates Shelly's in-depth knowledge of the regulations, how they pertain to the law, and how they are applicable IRL. Shelly's personable approach and pleasant manner in communication makes it very easy to have been work with her and have productive discussions on the best next steps. She truly has a passion iternational for all things FDA and I've learned so much from her.